Quell Therapeutics Limited

Active11890040 Private limited company

Incorporated: 19 March 2019 (7 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: Annette Clancy
Luke Matthew Beshar
Catherine Elizabeth Bingham
all 9 directors
Owned by: Syncona Limited
Accounts type: Full
Region: Greater London
Address: 3rd Floor
Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 12 May 2027
Last conf. stmt: 28 April 2026

Officers 9 active

Officer details are public data from the Companies House register.

Clancy, Annette

Director · Appointed 13 June 2025

British

Born November 1954

Beshar, Luke Matthew

Director · Appointed 24 July 2024

American

Born May 1958 (68)

Bingham, Catherine Elizabeth, Dame

Director · Appointed 28 July 2023

Also at SV Health Managers LLP, Enara Bio Limited, Alchemab Therapeutics Ltd · more companies

British

Born October 1965 (61)

Rivers, Tyrell Jermaine

Director · Appointed 2 June 2023

American

Born November 1972

Long-Mcgie, Jeffrey Stephen

Director · Appointed 24 November 2021

American

Born February 1976 (50)

Lechler, Robert Ian, Sir

Director · Appointed 2 June 2020

British

Born December 1951 (74)

Patel, Dhavalkumar D, Dr

Director · Appointed 2 June 2020

American

Born August 1961 (65)

Mcgill, Iain Robert

Director · Appointed 1 January 2020

British

Born May 1972 (54)

Petris, Elisa Michela, Dr

Director · Appointed 19 March 2019

Also at Beacon Therapeutics Holdings Limited · more companies

Italian,Canadian

Born January 1979 (47)

Officer history (6 former)

13 June 2025

Appointed Clancy, Annette as Director

31 May 2025

Resigned Mears, Rachel Brooke as Director

24 July 2024

Appointed Beshar, Luke Matthew as Director

8 March 2024

Resigned Mitre Secretaries Limited as Corporate Secretary

31 December 2023

Resigned Murphy, Martin Patrick, Dr as Director

15 August 2023

Resigned Ashrafian, Houman, Professor as Director

28 July 2023

Appointed Bingham, Catherine Elizabeth, Dame as Director

2 June 2023

Appointed Rivers, Tyrell Jermaine as Director

24 November 2021

Resigned Fueyo, Alberto Sanchez, Professor as Director

24 November 2021

Appointed Ashrafian, Houman, Professor as Director

24 November 2021

Appointed Long-Mcgie, Jeffrey Stephen as Director

24 November 2021

Appointed Mears, Rachel Brooke as Director

28 February 2021

Resigned Rhind, Stephen Keith as Director

2 June 2020

Appointed Lechler, Robert Ian, Sir as Director

2 June 2020

Appointed Patel, Dhavalkumar D, Dr as Director

1 January 2020

Appointed Mcgill, Iain Robert as Director

29 March 2019

Appointed Rhind, Stephen Keith as Director

29 March 2019

Appointed Fueyo, Alberto Sanchez, Professor as Director

19 March 2019

Appointed Petris, Elisa Michela, Dr as Director

19 March 2019

Appointed Murphy, Martin Patrick, Dr as Director

19 March 2019

Appointed Mitre Secretaries Limited as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Syncona Limited

Corporate entity · Notified 29 March 2019

Owns 25–50% of shares

Holds 25–50% of voting rights

Non-Cellular Company

Reg. no. 55514

Former controllers (1)

29 March 2019

Ceased Syncona Portfolio Limited — Owns 50–75% of shares

Filings 88

Date	Description	Made Up To
9 June 2026	Full accounts	31 December 2025
15 May 2026	Confirmation statement with updates	28 April 2026
13 May 2026	Director's details changed
13 May 2026	Director's details changed
11 May 2026	Director's details changed